-
1
-
-
0030898844
-
Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life
-
American Psychiatric Association (1997) Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. Am. J. Psychiat. 154(Suppl.), 1-39.
-
(1997)
Am. J. Psychiat.
, vol.154
, Issue.SUPPL.
, pp. 1-39
-
-
-
2
-
-
0029095547
-
Tacrine for Alzheimer's disease: A complex decision
-
Davis, K. L. (1995) Tacrine for Alzheimer's disease: A complex decision. Irish J. Psychol. Med. 12, 85-86.
-
(1995)
Irish J. Psychol. Med.
, vol.12
, pp. 85-86
-
-
Davis, K.L.1
-
3
-
-
0016823810
-
'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician
-
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975) 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
-
(1975)
J. Psychiatr. Res.
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
4
-
-
0008941101
-
-
July 7, 1989. Dept of Health and Human Services, Public Health Service, Rockville, MD
-
Food and Drug Administration (1989) Peripheral and Central Nervous System Drugs Advisory Committee Meeting, July 7, 1989. Dept of Health and Human Services, Public Health Service, Rockville, MD, p. 227.
-
(1989)
Peripheral and Central Nervous System Drugs Advisory Committee Meeting
, pp. 227
-
-
-
5
-
-
0002614656
-
Specialist memory clinics; the experience at the Hammersmith Hospital
-
Kelly, C. A., Harvey, R. J., Stevens, S. J., Nicholl, C. G. and Pitt, B. M. N. (1995) Specialist memory clinics; the experience at the Hammersmith Hospital. Facts Res. Gerontol. 1, 21-30.
-
(1995)
Facts Res. Gerontol.
, vol.1
, pp. 21-30
-
-
Kelly, C.A.1
Harvey, R.J.2
Stevens, S.J.3
Nicholl, C.G.4
Pitt, B.M.N.5
-
6
-
-
0031041005
-
Drug treatments for Alzheimer's disease raise clinical and ethical problems
-
Kelly, C. A., Harvey, R. J. and Cayton (1997) Drug treatments for Alzheimer's disease raise clinical and ethical problems. Brit. Med. J. 314, 693-694.
-
(1997)
Brit. Med. J.
, vol.314
, pp. 693-694
-
-
Kelly, C.A.1
Harvey, R.J.2
Cayton3
-
7
-
-
0030035653
-
Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality, Tacrine Study Group
-
Knopman, D., Schneider, L., Davis, K., Talwalker, S., Smith, F. and Hoover, T. (1996) Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality, Tacrine Study Group. Neurology 47, 166-167.
-
(1996)
Neurology
, vol.47
, pp. 166-167
-
-
Knopman, D.1
Schneider, L.2
Davis, K.3
Talwalker, S.4
Smith, F.5
Hoover, T.6
-
8
-
-
0030791258
-
Guidelines on drug treatments for Alzheimer's disease
-
Lovestone, S., Graham, N. and Howard, R. (1997) Guidelines on drug treatments for Alzheimer's disease. Lancet 350, 232-233.
-
(1997)
Lancet
, vol.350
, pp. 232-233
-
-
Lovestone, S.1
Graham, N.2
Howard, R.3
-
9
-
-
0028520744
-
Potential effects of tacrine on expenditure for Alzheimer's disease
-
Lubeck, D. P., Mazonson, P. D. and Bowe, T. (1994) Potential effects of tacrine on expenditure for Alzheimer's disease. Med. Interface 7, 130-138.
-
(1994)
Med. Interface
, vol.7
, pp. 130-138
-
-
Lubeck, D.P.1
Mazonson, P.D.2
Bowe, T.3
-
10
-
-
0031580695
-
Issues in drug treatment for Alzheimer's disease
-
Mackay, A. V. P. (1997) Issues in drug treatment for Alzheimer's disease. Lancet 350, 886-887.
-
(1997)
Lancet
, vol.350
, pp. 886-887
-
-
Mackay, A.V.P.1
-
11
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
-
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
12
-
-
0027954340
-
Alzheimer's disease and caregiver time
-
Moore, M. J. (1994) Alzheimer's disease and caregiver time. Lancet 343, 239-240.
-
(1994)
Lancet
, vol.343
, pp. 239-240
-
-
Moore, M.J.1
-
13
-
-
10244259208
-
The efficacy and safety of donepezil in patients with Alzheimer's disease. Results of a US multicentre, randomized, double-blind, placebo-controlled trial
-
Rogers, S. L. and Friedhoff, L. T. (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease. Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293-303.
-
(1996)
Dementia
, vol.7
, pp. 293-303
-
-
Rogers, S.L.1
Friedhoff, L.T.2
-
14
-
-
0031983322
-
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study
-
Rogers, S. L. and Friedhoff, L. T. (1998) Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study. Eur. Neuropsychopharmacol. 8, 67-75.
-
(1998)
Eur. Neuropsychopharmacol.
, vol.8
, pp. 67-75
-
-
Rogers, S.L.1
Friedhoff, L.T.2
-
15
-
-
0031883716
-
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
-
Donepezil Study Group
-
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R. and Friedhoff, L. T. (1998) Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50, 136-145.
-
(1998)
Neurology
, vol.50
, pp. 136-145
-
-
Rogers, S.L.1
Farlow, M.R.2
Doody, R.S.3
Mohs, R.4
Friedhoff, L.T.5
-
16
-
-
0021520020
-
A new rating scale for Alzheimer's disease
-
Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984) A new rating scale for Alzheimer's disease. Am. J. Psychiat. 141, 1356-1364.
-
(1984)
Am. J. Psychiat.
, vol.141
, pp. 1356-1364
-
-
Rosen, W.G.1
Mohs, R.C.2
Davis, K.L.3
-
17
-
-
0030850301
-
Interim statement on anti-dementia drugs - Implications, concerns and policy proposals
-
Royal College of Psychiatrists (1997) Interim statement on anti-dementia drugs - implications, concerns and policy proposals. Psychiatr. Bull. 21, 586-587.
-
(1997)
Psychiatr. Bull.
, vol.21
, pp. 586-587
-
-
-
18
-
-
0024995599
-
Longitudinal evaluation of dementia of the Alzheimer's type: A comparison of 3 standardized mental status examinations
-
Salmon, D. P., Thal, L. J., Butters, N. and Heindel, W. C. (1990) Longitudinal evaluation of dementia of the Alzheimer's type: A comparison of 3 standardized mental status examinations. Neurology 40, 1225-1230.
-
(1990)
Neurology
, vol.40
, pp. 1225-1230
-
-
Salmon, D.P.1
Thal, L.J.2
Butters, N.3
Heindel, W.C.4
-
19
-
-
0028262405
-
A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration
-
Stern, R. G., Mohs, R. C., Davidson, M., Schmeidler, J., Silverman, J., Kramer-Ginsberg, E. et al. (1994) A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration. Am. J. Psychiat. 151, 390-396.
-
(1994)
Am. J. Psychiat.
, vol.151
, pp. 390-396
-
-
Stern, R.G.1
Mohs, R.C.2
Davidson, M.3
Schmeidler, J.4
Silverman, J.5
Kramer-Ginsberg, E.6
-
20
-
-
0031749283
-
Assessment of progression and prognosis in Alzheimer's disease
-
Swanwick, G. R. J., Coen, R. F., Kidd, N., Lawlor, B. A., O'Neill, D., Walsh, J. B. et al. (1998) Assessment of progression and prognosis in Alzheimer's disease. Int. J. Geriatr. Psychiat. 13, 331-335.
-
(1998)
Int. J. Geriatr. Psychiat.
, vol.13
, pp. 331-335
-
-
Swanwick, G.R.J.1
Coen, R.F.2
Kidd, N.3
Lawlor, B.A.4
O'Neill, D.5
Walsh, J.B.6
|